PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32457362-0	2020	Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways.	regorafenib	0-11	Fos proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	113-116	
32457362-7	2020	Regorafenib treatment inhibits known receptor tyrosine kinase targets RET and PDGFRbeta and intracellular signalling through the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways.	regorafenib	0-11	Fos proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	157-160